Oral Vancomycin

Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin

Beneficial Bacteria Treatment for Autism

First-in-human Study of VE303 in Healthy Adult Volunteers

Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients

Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers

VE303 for Treatment of Hepatic Encephalopathy (HE)

Vancomycin in Primary Sclerosing Cholangitis in Italy

Maternal Probiotic Intervention to Improve Gut Health - Trial II - Bangladesh

Maternal Probiotic Intervention to Improve Gut Health - Trial II - Burkina Faso (MPIGH-II)

Maternal Probiotic Intervention to Improve Gut Health-Trial II-Pakistan

Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects

Oral Vancomycin Vs Placebo in the Prevention of Recurrence of Clostridioides Difficile's Infection

Oral Vancomycin for Preventing Clostridium Difficile Recurrence

TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment

Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics

Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI)

A Systems Biology Approach for Identification of Host and Microbial Mechanisms and Druggable Targets for the Treatment of PSC-IBD